Homepage Header Slider - Slide 1PIONEERING OFF-THE-SHELF
T-CELL IMMUNOTHERAPIES
Slider

 

 

Atara Biotherapeutics is a leading “off-the-shelf” T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune diseases.

Our “off-the-shelf”, or allogeneic, T-cells are engineered from donors with healthy immune function and allow for rapid delivery to patients without a requirement for pretreatment.

Originating from over a decade of groundbreaking clinical experience at Memorial Sloan Kettering and QIMR Berghofer, Atara’s T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.